INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
Report Outlook
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 355.85 Billion by 2029 | 12.6% | North America |
| By Type | By Application | By Region |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Biomaterials Market Overview
The global Biomaterials Market is expected to grow at 12.6% CAGR from 2020 to 2029. It is expected to reach above USD 355.85 Billion by 2029 from USD 122.30 Billion in 2020.
Biomaterials are man-made materials, either synthetic or natural, that are used in medical technology to restore injured tissues, bones, and organs to their original functionality. Medical implants and gadgets that replace or complement natural body functions use these biological components. The body does not allow any foreign material to totally increase its biological operations; hence implantable biomaterials are designed to decrease the negative immune reaction while maintaining proper performance. These biomaterials interact with biological systems to achieve medical goals such as the treatment of cardiovascular, dental, orthopedic, and neurological conditions.
The production of medical devices has been transformed by biomaterials. These substances are supple, simple to manufacture, highly biocompatible, inert, and very powerful. The development of biomaterials for implants and regeneration has increased the success rate of implants. They are employed in a variety of procedures, including joint replacements, bone plates, bone cement, artificial ligaments and tendons, dental implants for tooth fixation, blood vessel prostheses, heart valves, artificial tissue, contact lenses, and breast implants, all of which support the market’s expansion.
To assure their effectiveness and quality, biomaterial-based devices must go through a rigorous clinical and regulatory process. The majority of biomaterial devices are implantable, which is the main cause of this. As a result, before receiving market approval, they must go through a number of clinical and regulatory processes that are intricate, dependent on composition, and constrained. The market participants are reluctant to invest in this market as a result. These are the variables that are anticipated to impede market expansion over the forecast period.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), (Thousand Units) |
| Segmentation | By Type, Application and region. |
| By Type
 |
|
| By Application
 |
|
| By Region
 |
|
Governments from underdeveloped and developing countries funding the research in fields of biomaterials. Those nations are having poor health care and it provide great opportunity as the need for advanced healthcare services and novel medical equipment in the respective healthcare systems of these nations is anticipated to be driven by reasons such as the rising geriatric population, the rising incidence of target diseases, and the rising demand for surgical procedures. In the upcoming years, this is anticipated to present participants in the biomaterials market with prospective growth prospects.
Workflows in the worldwide healthcare industry have been hampered by the COVID-19. Numerous industries, including parts of the healthcare industry, have been temporarily forced to shut down due of the disease. Due to the worldwide economic downturn brought on by COVID-19, the global biomaterials market’s revenue also decreased. The COVID-19 pandemic had a significant influence on the functioning of general hospital treatment for patients who did not have the COVID-19 infection in hospitals around the world. The market for orthopedic implants is anticipated to be muted in the short term as a result of the lockdowns that prevented many hospitals and clinics from opening, which also lowers the need for biomaterial. However, with increased R&D for quick COVID-19 detection tests employing gold nanoparticles, which is anticipated to boost market growth, the industry is anticipated to rebound in the following one to two years.
Biomaterials Market Segment Analysis
The biomaterials market is segmented by type and by applications. In type segmentation can be further divided into metallic, polymeric, ceramic, and natural. The ageing population’s impact on the frequency and prevalence of chronic diseases as well as patients’ desire to retain their current level of activity and quality of life have all contributed to a substantial increase in the usage of implants over the past few years. The need for high-performance implantable biomaterials that can handle special challenges in cardiology, vascular therapy, orthopedics, trauma, spine, dental, and wound care has consequently been constantly growing. The excellent electrical, thermal, and mechanical properties of metals make them suitable as biomaterials. Furthermore, the accessibility of bioactive ceramics like hydroxyapatite has increased the bone’s conductivity. Thus, the patient’s quality of life has recently been greatly enhanced by the widespread use of metals in numerous applications. Making metallic type biomaterial most used type of biomaterials.
Based on application there are cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, tissue engineering these many classifications where the increase in use of biomaterials in cutting-edge cardiovascular devices is related to both the rising prevalence of cardiovascular illnesses and the two factors mentioned earlier. In terms of heart regeneration and repair, they show considerable promise. Among the other key application areas is the orthopedic sector. The prevalence of orthopedic replacements is predicted to increase during the forecast period, and novel biomaterials will also likely contribute to this trend.
Biomaterials Market Players
The Biomaterials Market key players include Koninklijke DSM N.V., Corbion N.V., EPTAM Plastics, Ltd., DiSanto Technology Inc., CoorsTek Medical LLC, Carpenter Technology Corporation, Zapp AG, United Titanium, Inc., Celanese Corporation, Victrex Plc, BASF SE, Evonik Industries AG
For corporate expansion, these key leaders are implementing strategic formulations such as new product development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending on product development, which is fueling revenue generation.
March 2022, Evonik Industries commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target. This product development improved the biocompatibility, safety, and performance of implantable products used by medical device customers and further strengthened Evonik’s growth.
September 2022, DSM announces a collaboration with PBC Biomed, a medical device design and development company to jointly design and develop novel materials for medical devices. Initially, the agreement will focus on the development of bone adhesives through PBC Biomed’s affiliate, Biomimetic Innovations, which could help to meet the need for safer, less invasive surgical procedures that are also more cost-effective.
Who Should Buy? Or Key Stakeholders
- Investors
- Raw Materials Manufacturer
- Healthcare Companies
- Research Organizations
- Regulatory Authorities
- Institutional & retail players
- Others
Biomaterials Market Regional Analysis
The Biomaterials Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and Rest of APAC
- Europe: includes the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA
The market is dominant in region of North America the reason behind is attributed to soaring healthcare costs, growing public acceptance, and expanding awareness of implantable medical technology. Additionally, the region demand for biomaterials is being fueled by the existence of a sizable number of market participants, an increase in the need for implantable devices, and an increase in the number of knee and hip replacement surgeries. The regional industry is also being driven by women’s growing interest in plastic surgery procedures like breast augmentation, facelifts, liposuction, and breast lifts.
A growing healthcare infrastructure, an increase in the prevalence of ophthalmic, neurological, cardiovascular, and orthopedic disorders, an increase in disposable incomes, the presence of well-established domestic companies, and an ageing population in the region all present lucrative opportunities for key players operating in the biomaterials market. As a result, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period.
Key Market Segments: Biomaterials Market
Biomaterials Market By Type, 2020-2029, (USD Billion), (Thousand Units)
- Metallic
- Polymeric
- Ceramic
- Natural
Biomaterials Market By Application, 2020-2029, (USD Billion), (Thousand Units)
- Cardiovascular
- Dental
- Orthopedic
- Wound Healing
- Plastic Surgery
- Ophthalmology
- Tissue Engineering
Biomaterials Market By Region, 2020-2029, (USD Billion), (Thousand Units)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the biomaterials market over the next 7 years?
- Who are the major players in the biomaterials market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-pacific, middle east, and Africa?
- How is the economic environment affecting the biomaterials market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the biomaterials market?
- What is the current and forecasted size and growth rate of the global biomaterials market?
- What are the key drivers of growth in the biomaterials market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the biomaterials market?
- What are the technological advancements and innovations in the biomaterials market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the biomaterials market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the biomaterials market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of biomaterials in the market and what is the impact of raw material prices on the price trend?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Biomaterials Market outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 on Biomaterials Market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global Biomaterials Market outlook
- GLOBAL BIOMATERIALS MARKET BY TYPE, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- Metallic
- Polymeric
- Ceramic
- Natural
- GLOBAL BIOMATERIALS MARKET BY APPLICATION, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- Cardiovascular
- Dental
- Orthopedic
- Wound Healing
- Plastic Surgery
- Ophthalmology
- Tissue Engineering
- GLOBAL BIOMATERIALS MARKET BY REGION, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles*
(Business Overview, Company Snapshot, Products Offered, Recent Developments)
- Koninklijke DSM N.V
- Corbion N.V.
- EPTAM Plastics, Ltd.
- DiSanto Technology Inc
- CoorsTek Medical LLC
- Carpenter Technology Corporation
- Zapp AG
- United Titanium, Inc.
- Celanese Corporation
- Victrex Plc
- BASF SE
- Evonik Industries AG
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY REGION (USD BILLION), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS MARKET BY REGION (THOUSAND UNITS), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOMATERIALS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â US BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â US BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â US BIOMATERIALS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â US BIOMATERIALS MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA BIOMATERIALS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA BIOMATERIALS MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOMATERIALS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOMATERIALS MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC BIOMATERIALS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE BIOMATERIALS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â ITALY BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â ITALY BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â ITALY BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â Â Â UAE BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â Â Â UAE BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â Â Â UAE BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â Â Â UAE BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 131Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 132Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 133Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 134Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 135Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 136Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOMATERIALS MARKET BY END USER (THOUSAND UNITS), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY TYPE, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY APPLICATION, USD BILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY REGION, USD BILLION, 2020-2029
FIGURE 11          PORTER’S FIVE FORCES MODEL
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY TYPE, USD BILLION, 2021
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY APPLICATION, USD BILLION, 2021
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL BIOMATERIALS BY REGION, USD BILLION, 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 16Â Â Â Â Â Â Â Â Â Â KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â CORBION N.V.: COMPANY SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â EPTAM PLASTIC LTD.: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â DISANTO TECHNOLOGY INC.: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â COORSTEK MEDICAL LLC: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â ZAPP AG: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â UNITED TITANIUM INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â CELANESE CORPORATION: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â VICTREX PLC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â BASF SE: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
FAQ
The global Biomaterials Market is expected to grow at 12.6% CAGR from 2020 to 2029. It is expected to reach above USD 355.85 Billion by 2029 from USD 122.30 Billion in 2020.
North America held more than 42% of the Biomaterials Market revenue share in 2020 and will witness tremendous expansion during the forecast period.
The production of medical devices has been transformed by biomaterials. These substances are supple, simple to manufacture, highly biocompatible, inert, and very powerful. The development of biomaterials for implants and regeneration has increased the success rate of implants. They are employed in a variety of procedures, including joint replacements, bone plates, bone cement, artificial ligaments and tendons, dental implants for tooth fixation, blood vessel prostheses, heart valves, artificial tissue, contact lenses, and breast implants, all of which support the market’s expansion.
The Health Care sector is major sector where the application of Biomaterials has seen more.
The Markets largest share is in the North America region.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.